Cemic

Ciudad Autonoma de Buenos Aires, Buenos Aires C1431FWO

2 studies enrolling now · 5 studies all time

What they study most

Extensive Stage Small-cell Lung Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Locally Advanced Metastatic NSCLC, Locally Advanced Unresectable NSCLC, Metastatic Colorectal Cancer, Non Small-cell Lung Cancer, Small Cell Lung Cancer (SCLC), Small-cell Lung Cancer

Studies at this site

• Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation — Recruiting now
• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling
• Expanded Access of Sotorasib — NO_LONGER_AVAILABLE